Parkinson’s disease in adults
Año de publicación: 2017
This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care.
Parkinson Disease/drug therapy, Parkinson Disease/diagnosis, Neuroprotective Agents/therapeutic use, Vitamin E/therapeutic use, Dopamine Agonists/therapeutic use, Monoamine Oxidase Inhibitors/therapeutic use, Parkinson Disease/therapy, Occupational Therapy, Levodopa/therapeutic use, Carbidopa/therapeutic use, Palliative Care